Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase I
IMV Inc. to Present at Upcoming Investor Conference
Phase III
Kodiak Sciences to Host R&D Day on October 14 in San…
Phase I
Roche Vice Chairman Calls for Long-Term Thinking by Business to Save…
Approval
Marizyme Agrees to Distribute Somahlution’s DuraGraft Products in South America and…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
European Results From Global ETNA-AF Registry Show Low Bleeding and Low…
Deals
Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove…
Commercial
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Commercial
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim…
Home
Therapy areas
Orphan-paediatric
Orphan-paediatric
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Orphan-paediatric
Research Roundup: New Test for Autism and More
Biospace News
-
July 12, 2019
Orphan-paediatric
Studies Show Sarepta’s Exondys 51 Slows Respiratory Decline in Muscular Dystrophy Patients
Orphan-paediatric
Novartis reports positive interim Phase III data for Zolgensma gene therapy candidate in SMA type 1
Orphan-paediatric
Industry and Advocacy Groups Urge FDA to Allow More Real-World Data for Rare Disease Trials
Orphan-paediatric
Axovant Releases Positive Interim Updates for Parkinson’s and Tay-Sachs Gene Therapy Trials
Orphan-paediatric
ArQule Announces Publication of Clinical Data with Miransertib in Proteus Syndrome
Biospace News
-
February 25, 2019
0
Orphan-paediatric
Drug for children with spinal muscular atrophy too expensive, HSE says ...
Firstwordpharma News
-
February 22, 2019
0
Orphan-paediatric
FDA Grants Priority Review and Accepts sBLA of SOLIRIS (Eculizumab) as...
Firstwordpharma News
-
February 22, 2019
0
Orphan-paediatric
Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2...
Firstwordpharma News
-
February 21, 2019
0
Orphan-paediatric
Deloitte Predicts Pharma Growth Driven by Orphan Disease Drugs and External...
Biospace News
-
February 20, 2019
0
1
2
3
...
5
Page 1 of 5
- Advertisement -
MOST POPULAR
Galderma Presented Final Results from Phase 2b Study of Nemolizumab in...
March 8, 2019
Akebia Therapeutics Announces Positive Top-Line Results from Two Pivotal Phase 3...
March 12, 2019
Synaffix Announces License Agreement Worth up to $125 Million with Leading...
April 10, 2019
Actelion, a J&J Division, Ponies up $360 Million to Settle U.S....
December 7, 2018
Load more
HOT NEWS
Deals
Innovent Announces a Collaboration with Chipscreen Biosciences to Evaluate the Combination...
Phase III
Biohaven Enrolls First Patient In Phase 3 Spinocerebellar Ataxia Clinical Trial...
Immuno-oncology
Actinium Pharmaceuticals to Host Key Opinion Leader Breakfast on Targeted Conditioning...
Commercial
Selecta Biosciences Presents New Preclinical Data from its Gene Therapy Program...
